Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Gilead Investors' Nightmare Scenario
Motley Fool
Saturday, September 14, 2013 - 10:45am
tags:
Gilead Sciences
4 Healthcare Stock Stories Making a Buzz On Friday
Wall St Cheat Sheet
Saturday, September 14, 2013 - 10:44am
tags:
Teva Pharmaceuticals, Ariad Pharmaceuticals, Alexion, Galena Biopharma
Data from Alexion's Soliris Study
Yahoo/Zacks
Saturday, September 14, 2013 - 10:41am
tags:
Alexion, acute antibody-mediated rejection, kidney transplants, transplant, Soliris
Regeneron Pharma Soars As Sanofi Mulls Doubling Stake
investors.com
Saturday, September 14, 2013 - 10:39am
tags:
Regeneron, Sanofi
Top Biotech Stock Picks for Q4 2013: An Interview with the Senior Analyst at Oppenheimer & Company
Yahoo/Wall St Transcript
Saturday, September 14, 2013 - 10:38am
tags:
Amgen, Celgene, ONYX Pharmaceuticals, Keryx, Pluristem Therapeutics, NPS Pharmaceuticals
Can This Biotech Star Deliver for Dividend Investors?
Motley Fool
Saturday, September 14, 2013 - 10:35am
tags:
Amgen
3 Key Takeaways From Isis' Investor Roadshow Week
Motley Fool
Friday, September 13, 2013 - 3:50pm
tags:
Isis Pharmaceuticals, ISIS-APOCIIIRx, Biogen Idec
Astex Sued by Shareholder Over $886 Million Otsuka Bid
Bloomberg
Friday, September 13, 2013 - 3:44pm
tags:
Astex, shareholders, Otsuka, M&A
Bayer AG comes under investigation in China
Yahoo/AP
Friday, September 13, 2013 - 3:44pm
tags:
Bayer AG, China
Lilly files $500 million lawsuit against Canada
Fierce Pharma
Friday, September 13, 2013 - 9:18am
tags:
Canada, Eli Lilly, patents
Actavis, Gilead, Valeant: Outlook For Health Stocks
Investors.com
Friday, September 13, 2013 - 9:16am
tags:
Valeant Pharmaceuticals, Actavis, Gilead
No Generic Zytiga Benefits Medivation
Minyanville
Friday, September 13, 2013 - 9:15am
tags:
generics, Medivation, Zytiga
How Cellceutix Acquired A Next Generation Antibiotic For Pennies On The Dollar
Seeking Alpha
Friday, September 13, 2013 - 9:13am
tags:
Cellceutix, antibiotics, Organovo, Cubist Pharmaceuticals, Celgene, Trius Therapeutics, Tetraphase Pharmaceuticals, Pfizer, MRSA, Optimer Pharmaceuticals, Dificid, Brilacidin
Cell Therapeutics raises $14.8M in convertible preferred stock sale
Yahoo/Fly on the Wall
Friday, September 13, 2013 - 9:10am
tags:
Cell Therapeutics
Alexion's Soliris receives marketing approval in Japan
The Fly on the Wall
Friday, September 13, 2013 - 9:09am
tags:
Japan, Soliris, Alexion, atypical hemolytic uremic syndrome
Roche Perjeta Wins Panel Backing for Early Breast Cancer
Bloomberg
Friday, September 13, 2013 - 8:42am
tags:
Roche, Perjeta, breast cancer, FDA, advisory panels
A Slight Stink For The Controversial Amarin Fish Oil Pill?
Pharmalot
Friday, September 13, 2013 - 8:40am
tags:
Amarin, Vascepa, Teva, Lovaza
Keyrx receives a vote of confidence
Yahoo/optionMONSTER
Friday, September 13, 2013 - 8:38am
tags:
Keyrx
AbbVie Has Excellent Management Efficiency, But Is It A Buy?
Seeking Alpha
Friday, September 13, 2013 - 8:36am
tags:
AbbVie, Neurocrine, Abbott Labs
Will This Biotech Approval Start a $100 Billion Trend?
Motley Fool
Friday, September 13, 2013 - 8:34am
tags:
drug approvals, Hospira, Remicade, biosimilars

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.